1. No category

Curriculum Vitae Tracy A. Brooks, Ph.D.
Contact Information
Department of BioMolecular Sciences
Division of Pharmacology
College of Pharmacy
University of Mississippi
315 Faser Hall
University, MS 38677
(662) 915-2309
tabrooks@olemiss.edu
Lab website: http://olemissbrookslab.weebly.com/
Chronology of Education
Undergraduate and Graduate
B.S.
1999
University of Rochester, Rochester, NY
Major: Microbiology and Immunology
Minor: Philosophy
Cum laude
Ph.D.
2003
SUNY Buffalo, Roswell Cancer Institute Division, Buffalo, NY
Department of Molecular Pharmacology and Cancer Therapeutics
Advisor: Ralph J. Bernacki, Ph.D.
Thesis: Overcoming Multidrug Resistance with Non-cytotoxic Taxanes
Postgraduate
2003 – 2004
Postdoctoral Fellow, Roswell Park Cancer Institute
Department of Medicine
Adviser: Maria R. Baer, MD
Modulation of MDR and BCRP with taxane-based analogs, an SAR study
2004 – 2006
Postdoctoral Fellow, University of Arizona
Department of Medicine
Adviser: Thomas P. Davis, Ph.D.
The Brain in Pain, how peripheral pain globally and regionally alters the
blood-brain barrier
Chronology of Employment
2011 –
Assistant Professor, College of Pharmacy
University of Mississippi
BioMolecular Sciences Department
Pharmacology Division
G-quadruplex Laboratory
Curriculum Vitae
Brooks, Tracy A.
2011 –
Associate Member, UMMC Cancer Center
University of Mississippi Medical Center
2009 – 2011
Member, Research Faculty, BIO5 Institute
Tucson, Arizona
2007 – 2011
Member, Arizona Cancer Center
Tucson, Arizona
2007 – 2011
Assistant Research Scientist, College of Pharmacy
University of Arizona
G-quadruplex Laboratory
Research Professor, mentor: Laurence H. Hurley, PhD
2004 – 2006
Postdoctoral Fellow, University of Arizona
Blood-brain barrier Laboratory
Advisor: Thomas P. Davis
2003
Postdoctoral Fellow, Roswell Park Cancer Institute
Multidrug resistance in acute leukemias
Advisor: Maria R. Baer, MD
2000 – 2001
Statistical Intern, Gynecological Oncology Group
Analyzed clinical data using Ingres database
Proposed new parameter values or validated current set
Assisted in statistical interpretation of scientific standings
1999 – 2003
Graduate Research Assistant, SUNY Buffalo
Roswell Park Graduate Division
Molecular Therapeutics and Cancer Therapeutics
Advisor: Ralph J. Bernacki, PhD
2000
Volunteer Teacher, Buffalo, NY
Roswell Park Cancer Institute Summer Program for high school students
Honors and Awards
2014 – 2015
Teacher of the Year
University of Mississippi, School of Pharmacy PY2 year
2014 – 2015
Friend of the Students Award, Oxford Campus
University of Mississippi, School of Pharmacy Student Body
2014
New Investigator of the Year
University of Mississippi, School of Pharmacy
2012 – 2013
Teacher of the Year
University of Mississippi, School of Pharmacy PY2 year
2012 – 2013
Mentor
University of Mississippi McNair Program
2011
Competent Leader
Biosciences Toastmasters
2|Page
Curriculum Vitae
Brooks, Tracy A.
2010 – 2011
Mentor
NASA Space Grant Consortium
2010
Scientific Reviewer
Department of Defense, Breast Cancer Research Program
2010
Competent Communicator
(Women of) Biosciences Toastmasters
2009 – 2010
Mentor
Arizona Assurance Program
2009
Leader
Tucson’s Top 40 Under 40
2009 – 2011
Charter Member, VP Education and President
Women of Biosciences Toastmasters
2003
Predoctoral Scholar Travel Award
MDR in Cancer Forum, 1st Annual
Dublin, Ireland
2002
Winner, 1st place
RPCI Dean Mirand Graduate Research Forum
2000 – 2004
Woodburn Academic Fellow
Roswell Park Cancer Institute
1999 – 2000
Bertha Scott Fellow
Roswell Park Cancer Institute
1996 – 1999
Rush Rhees Scholar
University of Rochester
1996 – 1999
Bausch & Lomb Scholar
University of Rochester
Funding
Active
8/15/14 – 8/14/16
Principal Investigator
Department of Defense
PRCRP Career Development Award
CA130229
“Novel molecular targets for kRAS downregulation: promoter Gquadruplexes”
$333,878
7/1/2013 – 6/30/2016
Principal Investigator (PI: Brooks; co-I: Wadkins)
National Institutes of Health
R15 CA173667-01A1
“Deconvoluting G-quadruplex and i-Motif dynamics: the role of
physiological stressors”.
$421,799
3|Page
Curriculum Vitae
9/1/2011 –
Brooks, Tracy A.
Startup Funds
University of Mississippi
School of Pharmacy
$125,000
Pending American Cancer Society
Brooks (PI)
Targeting the silencing kRAS promoter G-quadruplex: a new molecular target
$792,000
NCI R21CA201689-01
Brooks (PI)
Block copolymer based delivery of MYC G-quadruplex targeted clamps: a new lymphoma nano
therapeutic
$383,676
Camille Dreyfus Scholar-Teacher Award Brooks (PI)
Noncanonical DNA formation and developmental regulation in zebrafish
$75,000
King’s College, Pancreatic Cancer UK
Rahmann (PI); Brooks (PI-subcontract)
Triaryl Benzofurans as chemical tools to study G4-mediated kRAS modulation in pancreatic cancer
$55,000
King’s College, King’s Health Partner
Rahmann (PI); Brooks (PI-subcontract)
Triaryl Benzofurans as chemical tools to study G4-mediated kRAS modulation in pancreatic and lung
cancer
$40,000
Previous 2010 – 2011
Co-Investigator, PI: Laurence Hurley
National Institutes of Health
“G-Quadruplex-Mediated Transcriptional Regulation of PDGF-β”
$3 million
2010 – 2011
Principal Investigator
National Institutes of Health
SPORE in Lymphoma, Scientific Development Award
“Developing PNA probes for G-quadruplex detection within the MYC promoter
in vivo”
$50,000
2007 – 2010
Co-Investigator, PI: Laurence Hurley
Leukemia and Lymphoma Society Translational Award
“Novel molecular therapies for lymphoma targeting transcriptional regulation of
c-Myc and Bcl-2”
2005 – 2007
Principal Investigator
Ruth L. Kirschstein NRSA Postdoctoral Award
4|Page
Curriculum Vitae
Brooks, Tracy A.
“Chronic Inflammatory Pain’s effect on the BBB”
2004 – 2005
Postdoctoral Fellow
Heart and Lung Training Grant
2000 – 2003
Predoctoral Fellow
Ruth L. Kirschstein Predoctoral Training Grant
Service
Local and Intramural Service, University of Mississippi
Service to the Department, School or College.
School of Pharmacy service:
2014 –
Pharmaceutics Faculty Search Committee
2014 – 2015
BioMolecular Sciences Faculty Search Committee
2014 –
Ad hoc Biomolecular Sciences Graduate Education Committee
2014
Scholastic Standards Committee Member
2013
NCNPR Translational Director Search Committee
2013 –
School of Pharmacy, PDAT advisor
2012 –
School of Pharmacy, Pre-Pharmacy advisor
2012
School of Pharmacy, PDAT Committee Member
2012 –
School of Pharmacy, Student Faculty Relations Committee, Secretary
(2012-2014) and Chair (2014 – )
2012
Pharmacology Department Chair Search Committee
Service to the University.
2014 – 2015
Judge: 4/28/15:
4/10/12:
4/4/12:
Chemical Engineering Faculty Search Committee
GSC Annual Poster Symposium and Research Day
2012 Mississippi EPSCoR Student Research Poster Competition
GSC 2nd Annual Poster Symposium and Research Day
Service to External Constituencies of the University.
2012 –
Faculty Advisor, Ole Miss Relay for Life (Am. Cancer Society)
2015
Keynote Speaker, 1st annual MS PurpleLight Event, Pancreatic Cancer
Action Network
Local and Intramural Service, University of Arizona
2009 – 2010
Mentor, Arizona Assurance Mentor
2009 – 2010
Panelist, Women in Science and Engineering
2005
Judge, Southern Arizona Regional Science and Engineering Fair
Extramural Service
2014
Scientific Reviewer, MRC SIR Grant Program
5|Page
Curriculum Vitae
Brooks, Tracy A.
2013
Scientific Reviewer, AACP NIA Grant Program
2010, 2015
Scientific Reviewer, DoD BCRP Program
2004 –
Journal Referee, Life Sciences, Journal of Pharmacology and
Experimental Therapeutics, American Journal of Physiology, Brain
Research, Journal of Cellular Physiology, Journal of Medicinal
Chemistry, Biochemistry, Nature Communications, Journal of Natural
Product, BMC Biochemistry, Chemistry and Biology, PLoS One, FEBS
Letters
Teaching
1. Formal Course Instruction
a. University of Mississippi (instructor grades out of 5)
i. PHCL 444, Spring 2012, 4 cr. lecture, Basic and Clinical Pharmacology II for PY2 Pharmacy
Students, 15 lectures; overall grade of instructor: 4.9, enrollment = 54
ii. PHCL 443, Fall 2012, 4 cr. lecture, Basic and Clinical Pharmacology I for PY2 Pharmacy
Students, 18 lectures; overall grade of instructor: NA, enrollment = 78
iii. PHCL 382, Fall 2012, 2 cr. lecture, Fundamentals of Cancer, elective for PY2 Pharmacy
Students, 32 lectures (course director); overall grade of instructor: 4.9, enrollment = 14
iv. PHCL 444, Spring 2013, 4 cr. lecture, Basic and Clinical Pharmacology II for PY2 Pharmacy
Students, 23 lectures (course director); overall grade of instructor: 4.4, enrollment = 74
v. PHCL 444r, Summer II 2012, 4 cr. lecture, Basic and Clinical Pharmacology II remediation
for PY2 Pharmacy Students, 9 lectures (course director); Overall grade of instructor: 5,
enrollment = 6
vi. PHCL 382, Fall 2013, 2 cr. lecture, Fundamentals of Cancer, elective for PY2 Pharmacy
Students, 32 lectures (course director); overall grade of instructor: 4.9, enrollment = 37
vii. PHCL 444, Spring 2014, 4 cr. lecture, Basic and Clinical Pharmacology II for PY2 Pharmacy
Students, 32 lectures (course director); overall grade of instructor: 4.9, enrollment = 107
viii. PHCL 564, Spring 2014, 4 cr. lecture, Introductory Pharmacology II for graduate
students in the Pharmaceutical Sciences, 32 lectures (course director); overall grade of
instructor: 4, enrollment = 7
ix. PHCL 643, Spring 2014, 1 cr. seminar, Seminar: Current Topics in Pharmacology and
Toxicology for Pharmacology graduate students, 16 meetings (course director); overall grade
of instructor: 3.6, enrollment = 12
x. PHCL 443, Fall 2014, 4 cr. lecture, Basic and Clinical Pharmacology I for PY2 Pharmacy
Students, 38 lectures (course director); overall grade of instructor: 4.7, enrollment = 120
xi. PHCL 563, Fall 2014, 4 cr. lecture, Basic and Clinical Pharmacology I for PY2 Pharmacy
Students, 38 lectures (course director); overall grade of instructor: NA, enrollment = 3
xii. PHCL 444, Spring 2015, 4 cr. lecture, Basic and Clinical Pharmacology II for PY2 Pharmacy
Students, 35 lectures (course director); overall grade of instructor: ongoing, enrollment = 113
xiii. PHCL 541, Spring 2015, 3 cr. lecture, Fundamentals of Cancer for graduate students, elective
for graduate students in the Pharmaceutical Sciences, 32 lectures (course director); overall
grade of instructor: ongoing, enrollment = 7
6|Page
Curriculum Vitae
Brooks, Tracy A.
b. University of Arizona
i. PCOL 837b, 2008 – 2010, Medicinal Chemistry for P2 Pharmacy students. Taught lectures in
Neuroregulation, Gonadal Hormones, and Targeted Cancer Therapeutics
ii. PCOL 820 and 821, 2008 – 2010, Case Studies in Pharmacology, Facilitator
iii. PhPr822, 2009 – 2010, Case discussions in Pharmacology and Pharmaceutical Chemistry,
Facilitator
c. Pima Community College (all as course instructor)
i. BIO 181IN, 2005, General Biology I for undergraduate science majors
ii. BIO 201IN, 2007 – 2011, Anatomy and Physiology I for nursing majors; taught in entirely
didactic and in hydrid online formats
iii. BIO 202IN, 2010 – 2011, Anatomy and Physiology I for nursing majors; taught in entirely
didactic and in hydrid online formats
iv. BIO 160IN, 2011, Anatomy and Physiology for non-majors
d. Cochise College (all as course instructor)
i. CHM130IN, 2005, Fundamental Chemistry for undergraduate science majors
ii. BIO101, 2006 – 2011, Introductory Biology for non-Majors, online-format
2. Course Development
a. PHCL 382, Fundamentals of Cancer for pre-pharmacy and graduate students, University of
Mississippi, School of Pharmacy, 2011 –
b. PHCL 643, Seminar: Topics in Pharmacology and Toxicology. Fall 2013 - Spring 2014 was
revised to provide student development with public speaking, including impromptu speeches,
consideration of “um’s”, and idiosyncrasies for individual students
3. Efforts to Improve Teaching
a. University of Mississippi
i. “Simple Steps Towards Transformative Teaching”, 2013
ii. “Record Lectures at Your Desk”, 2013
iii. “Make your PowerPoint Sizzle, not Fizzle”, 2013
iv. “Evidenced Based Strategies to Promote Student Learning and Academic Success”, 2015
b. American Association for Colleges of Pharmacy
i. Teaching Institute, 2013
c. CAE/CATS
i. Tier 1 Teaching Excellence Workshop, 2012
4. Awards and Recognition for Teaching
a. Mentor, Arizona Assurance Program, 2009 – 2010
b. Mentor, University of Arizona NASA Space Grant Consortium, 2010 – 2011
c. Mentor, University of Mississippi McNair Program for underrepresented minority students, 2012
– 2013
d. Teacher of the Year, University of Mississippi, School of Pharmacy, PY2, 2012 – 2013
e. Teacher of the Year, University of Mississippi, School of Pharmacy, PY2, 2014 – 2015
f. Friend of the Student, University of Mississippi, School of Pharmacy Student Body
5. Service for Teaching and Learning
a. Member, PDAT organization committee, University of Mississippi, School of Pharmacy, 2012
b. Advisor, Pre-Pharmacy program, University of Mississippi, School of Pharmacy, 2012 –
7|Page
Curriculum Vitae
Brooks, Tracy A.
c. Advisor, PDAT professional student program, University of Mississippi, School of Pharmacy,
2012 –
d. Secretary (2012 – 2014) and Chair (2014 – ), Student Faculty Relations Committee, University
of Mississippi, School of Pharmacy 2012 –
e. Member, Scholastic Standards Committee, University of Mississippi, School of Pharmacy 2014
f. Member, Honors and Awards Committee, University of Mississippi, School of Pharmacy 2014 –
g. Member, BioMolecular Sciences Graduate Education Realignment Committee, University of
Mississippi, School of Pharmacy, Department of BioMolecular Sciences, 2014 –
6. Advising and Mentoring
a. Graduate Research Supervision
Year
2008 – 2010
2009
2009 – 2011
Name
Jessica Fortin
Xi Chen
Robert Brown
2010
2010
2010 – 2011
Angela Davis
Cory Burgess
Christine Kaiser
2010 – 2011
2012
2012 – 2013
2012 – 2013
Caleb Sutherland
Heather Lewis
Jennifer (Chi-Fan)
Hockings, Ph.D.
Joseph Lee
2012 –
Tierra Gaillard
2013 –
2013 –
2014 –
2014 –
2014 –
2014
Keshia Dykes
Rhianna Morgan
Kandis Backus
Harshul Batra
Taisen Hao
Maria Laura Greco
Program of Study
Co-Advisor, Drug Discovery and Development
Laboratory Rotation, Drug Discovery and Development
Laboratory Rotation and thesis work, Drug Discovery and
Development
Laboratory Rotation, Drug Discovery and Development
Laboratory Rotation, Drug Discovery and Development
Laboratory Rotation and thesis work, Drug Discovery and
Development
Laboratory Rotation and thesis work, Cancer Biology
Laboratory Rotation, PharmD student
Laboratory Rotation and Pathways Project Co-advisor,
PharmD student
Laboratory Rotation and Pathways Project Supervisor,
PharmD student
Laboratory Rotation and Pathways Project Supervisor,
PharmD student
Thesis rotation, Chemistry and Biochemistry, M.S.
Thesis advisor, Pharmacology, Ph.D.
Thesis advisor, Pharmacology, Ph.D.
Thesis advisor, Pharmacology, Ph.D.
Thesis advisor, Pharmacology, Ph.D.
Ph.D. Candidate Intern from Italy, 3 months summer 2014
b. Undergraduate Student Research Supervision
Year
2004
Name
Caroline Quigley
2004 –
2006
2004 –
2006
2007 –
Rachel Charles
Nikki Nametz
Ravi Goyal
Program of Study
Undergraduate Independent
Research
Undergraduate Independent
Research
Undergraduate Independent
Research
Undergraduate Independent
Outcome
Graduated with B.S., Completed
M.D.
Graduated with B.S., currently in
medical school at UA
Graduated with B.S., Completed
M.D.
Graduated with B.S.
8|Page
Curriculum Vitae
2008
2008 –
2009
2008 –
2009
2008 –
2009
Vanessa Gaerig
2008 –
2010
2008 –
2009
2009 –
2011
Jessica Kashian
2009
Claudia Meece
2009 –
2010
2009 –
2011
2010 –
2011
2010
Ravi Ram
2010
2012
Megan
Wittenberg
Taesha Simmons
2012 –
Kristen Greer
2012 –
Rachel Jenkins
2013
Ashley King
2013 –
Neal Ainsworth
2013 –
2014
2014
Robert Ricks
Misha Pangasa
Matthew Karolak
Jessica Shelton
Forest Danford
Alexa
Williamson
Edward Bastidas
Kaity Kepler
Kelly Powell
Brooks, Tracy A.
Research Thesis project –
Biochemistry and Molecular
Biophysics (BMB)
Undergraduate Independent
Research Thesis project – BMB
Undergraduate Biology Research
Program
Undergraduate Independent
Research – Molecular and Cellular
Biology (MCB)
Undergraduate Independent
Research Thesis project – BMB
Undergraduate Independent
Research - Physiology
Undergraduate Independent
Research – Biomedical Engineering,
NASA Space Grant Consortium
Fellow
Summer Minority Health Disparities
Program
Undergraduate Independent
Research - Physiology
Undergraduate Independent
Research - MCB
Undergraduate Independent
Research - MCB
CapStone Project, Vail School
District, AZ
KEYS program, University of
Arizona
McNair Fellow, University of
Mississippi
Undergraduate Independent
Research – Pre-Pharmacy
Undergraduate Independent
Research – Pre-Pharmacy
McNair Fellow, University of
Mississippi
Undergraduate Independent
Research – Pre-Pharmacy
Undergraduate Independent
Research – Pre-Pharmacy
Undergraduate Independent
Graduated with B.S.
Completed Pharm.D. at UA
Graduated with B.S., Completed
M.D.
Graduated with B.S., obtaining
Ph.D. at Vanderbilt University
Graduated with B.S.
Works as industry technician in CA
Graduated with B.S.
Graduated with B.S.
Completed Pharm.D. at UA
Graduated with dual B.S.
Completed B.S.
Completed B.S. and R.N.
Current University of Arizona
Student
Graduated with B.S. from ASU
Completed B.S. in Biology at Rust
College
Graduated with BSPS, Current
PY2 in UM Pharm.D. program
Graduated with BSPS, advanding
PY2 in UM Pharm.D. program
Completed B.S. in Biology at
Tougaloo College
Graduated with BSPS, Current
PY2 in UM Pharm.D. program
Graduated with BSPS, Current
PY2 in UM Pharm.D. program
Honors student, graduated with
9|Page
Curriculum Vitae
Brooks, Tracy A.
Research
2014
Quinea Lassiter
2014 –
Melissa Holy
2014 –
Abraham Kim
2014 –
Kelsey Raymer
Undergraduate Independent
Research – Summer 2014
Undergraduate Independent
Research – Pre-Pharmacy
Undergraduate Independent
Research – Pre-Pharmacy
Undergraduate Independent
Research – Pre-Pharmacy
B.S., pursuing Dental School at
UMMC
Completed B.S. at UA
Early Entry Pharmacy/Honors
student
Early Entry Pharmacy/Honors
student
Early Entry Pharmacy
c. Graduate Student Committee Service:
i. Krishna Nagalla, Ph.D. Pharmaceutical Sciences – Pharmacology, completed 2013
ii. Pranapda Aumsuwan, Ph.D. Pharmaceutical Sciences – Pharmacology, completed 2014
iii. Eric Bow, Ph.D. Pharmaceutical Sciences – Medicinal Chemistry, expected 2016
iv. Annie McClellan, M.S. Chemical Engineering, expected 2016
Teaching philosophy available upon request
Publications
Peer-Reviewed Articles
1.
Reilly, SM; Morgan, RK; Brooks, TA; Wadkins, RM. “Effect of Loop Length on the Thermal
Stability and pKa of i-Motif DNA”, Biochemistry, 2015 Feb 17; 54(6): 1364-1370.
2.
Bhavsar-Jog, Y; Dornshuld, E; Brooks, TA; Tschumper, G; Wadkins, RM. “Epigenetic
modification, dehydration, and molecular crowding effects on the thermodynamics of i-motif
structure formation from C-rich DNA”. Biochemistry, 2014 Feb 24; 53(10): 1586-1594.
3.
Brown, RV; Gaerig, VC; Simmons, T; and Brooks, TA. “Helping Eve Overcome ADAM: Gquadruplexes in the ADAM-15 Promoter as New Molecular Targets for Breast Cancer
Therapeutics”. Molecules, 2013 Dec 5; 18(12):15019-34.
4.
Boddupally PV, Hahn S, Beman C, De B, Brooks TA, Gokhale V, Hurley LH. “Anticancer
Activity and Cellular Repression of c-MYC by the G-Quadruplex-Stabilizing 11Piperazinylquindline Is Not Dependent on Direct Targeting of the G-Quadruplex in the cMYC Promoter”. JMC. 2012, July 12; 55(13): 6076-86.
5.
Brown, RV; Danford, FL; Gokhale, V; Hurley, LH; and Brooks, TA. “Demonstration that DrugTargeted Downregulation of MYC in Non-Hodgkins Lymphoma is directly mediated
through the promoter G-quadruplex”. JBC, 2011 Nov 25; 286(47):41018-27.
6.
Brooks TA; Hurley LH. Targeting MYC expression through G-quadruplexes. Genes and
Cancer. Invited Review, 2010 June; 1(6):641-649.
7.
Brooks TA; Kendrick SL; Hurley LH. Making sense of G-quadruplex and i-motif functions in
oncogene promoters. FEBS Journal. 2010, September; 277(17): 3459-3469. Chosen for
cover art.
10 | P a g e
Curriculum Vitae
Brooks, Tracy A.
8.
Brooks TA; Hurley LH. The role of supercoiling in transcriptional control of c-myc and its
importance in molecular therapeutics. Nature Reviews Cancer. 2009 Dec; 9(12):849-61.
9.
Qin Y; Tye D, Gleason-Guzman M; Fortin JS; Brooks TA; Hurley LH. Molecular cloning of the
human PDGFR-β promoter and drug targeting of the G-quadruplex-forming region to repress
PDGFR-β expression. Biochemistry. 2010 May; 49(19):4208-4219.
10.
Stasik CJ, Nitta H, Zhang W, Mosher CH, Cook JR, Tubbs RR, Unger JM, Brooks TA, Persky
DO, Wilkinson ST, Grogan TM, Rimsza LM. Increased MYC gene copy number correlates
with increased mRNA levels in diffuse large B-cell lymphoma. Haematologica. 2010 Apr;
95(4):597-603.
11.
McCaffrey G, Seelbach MJ, Staatz WD, Nametz N, Quigley C, Campos CR, Brooks TA, Davis
TP. Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by
peripheral inflammatory hyperalgesia. J Neurochem. 2008 Sep; 106(6):2395-409.
12.
Willis, CL; Brooks, TA; Davis, TP. Chronic inflammatory pain and the neurovascular unit: a
central role for glia in maintaining BBB integrity? Curr Pharm Des. 2008; 14(16): 1625-43.
Author erratum, 2010. Chosen for cover art.
13.
Brooks, TA; Nametz, N; Charles, RA; Seelbach, MJ; Campos, CR; Davis, TP. Diclofenac
attenuates the regional effect of λ-carrageenan on BBB function and cytoarchitecture. JPET,
2008 May;325(2):655-73.
14.
McCaffrey G, Staatz WD, Quigley CA, Nametz N, Seelbach MJ, Campos CR, Brooks TA,
Egleton RD, Davis TP. Tight junctions contain oligomeric protein assembly critical for
maintaining blood-brain barrier integrity in vivo. J. Neurochemistry, 2007 Oct; 103(6) 25402555.
15.
Seelbach, MJ; Brooks, TA; Egleton, RD; Davis, TP. Peripheral inflammatory hyperalgesia
modulates morphine delivery to the brain: a role for P-glycoprotein. J. Neurochemistry, 2007
Sept; 102(5): 1677-1690.
16.
Brooks, TA; O’Loughlin, KL; Minderman, H; Bundy, BN; Ford, LA; Priebe, W; Bernacki, RJ;
Baer, MR. The 4’-O-Benzylated Doxorubicin Analog WP744 Overcomes Resistance
Mediated by P-Glycoprotein, Multidrug Resistance Protein and Breast Cancer Resistance
Protein in Cell Lines and Acute Myeloid Leukemia Cells. Invest New Drugs, 2007
Apr;25(2):115-22.
17.
Brooks, TA; Ocheltree, SM; Seelbach, MJ; Charles, RA; Nametz, N; Egleton, RD; Davis, TP.
Biphasic cytoarchitecture and functional changes in the BBB induced by chronic
inflammatory pain. Brain Research, 2006 Nov; 1120(1):172-82.
18.
Brooks, TA; Hawkins, BT; Huber, JD; Egleton, RD; Davis, TP. Chronic Inflammatory Pain
Leads to upregulation of Claudin-3 and Claudin-5 at the Blood-Brain Barrier. Chronic
inflammatory pain leads to increased blood-brain barrier permeability with tight junction
protein alterations. American Journal of Physiology-Heart and Circulatory Physiology, 2005
Aug; 289(2):H738-43.
19.
Ojima, I; Borella, CP; Wu, X; Bounaud, PY; Oderda, CF; Sturm, M; Miller, ML; Chakravarty, S;
Chen, J; Huang, O; Pera, P; Brooks, TA; Baer, MR; Bernacki, RJ. Design, synthesis and
structure activity relationships of novel taxane-based multidrug resistance reversal agents. J
Med Chem. 2005 Mar 24; 48(6):2218-28.
11 | P a g e
Curriculum Vitae
Brooks, Tracy A.
20.
Brooks, TA; Kennedy, D; Ojima, I; Baer, MR; Bernacki, RJ 2002. Structure-Activity Analysis
of taxane-based Multidrug Resistance Modulators. Anticancer Research, 24(2A):409-15,
2004.
21.
Minderman, H; Brooks, TA; O’Loughlin, K; Ojima, I; Bernacki, RJ; Baer, MR. Modulation of
ATP Binding- Cassette Binding Proteins by the Taxane Derivatives BAY 59-8862 and
tRA96023. Cancer Chemotherapy and Pharmacology 53(5): 363-369, 2004.
22.
Brooks, TA; Minderman, H; O’Loughlin, K; Ojima, I; Baer, MR; Bernacki, RJ. Taxane-based
Reversal Agent Modulation of Drug Transport Mediated by P-glycoprotein, Multidrug
Resistance Protein-1, and Breast Cancer Resistance Protein. Molecular Cancer Therapeutics
2: 1195-1205, 2003.
Patents and Book Chapters
1.
Provisional Patent (12.5% royalty rights), US 09-374, “G-quadruplex binding ligands and
methods for their use”. 2009.
2.
Brooks, TA. Modification of chemotherapeutic drugs to obtain potential MDR modulating
agents. Multi-drug resistance: biological and pharmaceutical advance in antitumour
treatment. Research Signpost, Ed. Nicola Colabufo, 2009.
Manuscripts Submitted and in Preparation
1.
Morgan, RK; Hockings, J; Gaerig, VC; Greer, KM; Kothalawala, N; Dass, A; Brooks, TA.
“New transcriptionally silencing G-quadruplex formations within the kRAS promoter” 2014,
Submited to BBA-Gene Regulatory Mechanisms. In revision
2.
Garcia-Huidobro, J; Dominguez, C; Brooks, TA; Gerner, EW. “Functional Consequence of
Genetic Variability in a G-Quadruplex Structure in the Ornithine DeCarboxylase (ODC1)
Gene”. 2014, Submitted to NAR. In revision.
3.
Hao, T; Gaerig, VC; Brooks, TA. “Nucleic Acid clamps engineered to detect and stabilize the
MYC G-quadruplex: a new therapeutic approach”. 2015, for submission to Nucleic Acids
Research.
4.
Brown, RV; Gaerig, VC; Brooks, TA. “Characterizing the formation and biological role of Gquadruplexes formed within the VEGFR2/KDR core promoter”. 2015, for submission to
BBA-GRM.
5.
Brown, RV; Danford, FL; Rimsza, LM; Hurley, LH; Brooks, TA. “Optimizing molecular
targeted therapies for Mantle Cell Lymphoma: targeting the c-MYC promoter.” 2015, for
submission to Blood.
Invited National and International Talks
1.
SERMACS, 2013. “Identification of new, biologically relevant, G-quadruplexes formed
within the critical promoter of kRAS as promising molecular targets”
2.
ACS Pacifichem, 2010. “Transcriptional downregulation of c-Myc via G-quadruplex
stabilization as novel therapy for non-Hodgkin lymphoma”
3.
Barriers of the CNS Gordon Conference, 2006.
12 | P a g e
Curriculum Vitae
Brooks, Tracy A.
4.
Neuroscience, 2005. “Chronic inflammatory pain alters BBB cytoarchitecture leading to
disruption of paracellular permeability”
5.
Multidrug Resistance, Biotechnology and Cancer Symposium, Dublin, Ireland, 2003
“Overcoming Multidrug Resistance with Non-cytotoxic Taxanes”
6.
Pharmacodynamics: From the Molecular to the Mathematical”, 2002 “Non-cytotoxic
taxanes which overcome multiple mechanisms of multidrug resistance: Pgp, MRP-1 and
BCRP”
7.
Pharmacological Sciences Day, University of Buffalo, 2002 “Modulatory Ability of
Taxane based Reversal Agents (tRA’s) against P-glycoprotein (Pgp)-, Multidrug Resistance
Protein (MRP-1)-, and Breast Cancer Resistance Protein (BCRP)- mediated Mitoxantrone
transport”
Conference Presentations (truncated at most recent 20)
1.
2.
3.
4.
5.
6.
7.
8.
9.
Morgan, R; Rahman, KM; Brooks, TA. Structure Elucidation of G-Quadruplex within the midregion of the kRAS Promoter and Identification of Stabilizing Small Molecules as Promising
Transcriptional Silencers. Proceedings of the American Association of Cancer Research
(AACR), April 2015. Abstract 1245.
Batra, H; Brooks, TA. The Effect of the transcription factor MAZ on kRAS transcription: a role
for the G-quadruplex. Proceedings of the American Association of Cancer Research
(AACR), April 2015. Abstract 2137.
Hao, T; Brooks, TA. Modulating nRAS mRNA translation by nucleic acid clamp-mediated
stabilization of the 5’-UTR G-quadruplex. Proceedings of the American Association of
Cancer Research (AACR), April 2015. Abstract 2110.
Morgan, R; Summerford, B; Bhavsar-Jog Y; Wadkins, RM; Brooks, TA. Effects of 5hydroxymethylcytosine epigenetic modification on G-quadruplex and i-Motif structure and
stability within the VEGF promoter. Proceedings of the American Association of Cancer
Research (AACR), April 2015. Abstract 6641.
Morgan, R*; Rahman, KM; Brooks, TA. Structure elucidation of G-quadruplex within the midregion of the kRAS promoter and identification of stabilizing small molecules as promising
transcriptional silencers. Mississippi Academy of Sciences Annual Meeting, Hattiesburg,
MS. February 2015. *1st place poster winner*
Morgan, R; Brooks, TA. G-Quadruplex Formation in kRAS Mid Promoter Region: A Potential
Therapeutic Target for Pancreatic Cancer. ACS Drug Discovery and Development
Colloqium, Little Rock, AR. June 2014.
Hao, T; Brooks, TA. Developing Linked Nucleic Acid Probes as Novel Non-Small Molecule
Cancer Therapeutics by Targeting G-Quadruplex in the Promoter Region of c-MYC ProtoOncogene. ACS Drug Discovery and Development Colloqium, Little Rock, AR. June 2014.
Batra, H; Brooks, TA. The Effect of the Transcription Factor MAZ on kRAS Expression: A
Role in Pancreatic Cancer. ACS Drug Discovery and Development Colloqium, Little Rock,
AR. June 2014.
Backus, K; Brooks, TA. A Novel Role for p53 in kRAS Binding in Pancreatic Cells. ACS Drug
Discovery and Development Colloqium, Little Rock, AR. June, 2014.
13 | P a g e
Curriculum Vitae
10.
11.
12.
13.
14.
Brooks, Tracy A.
King, A; Hockings, J; Brooks, TA. MAZ Regulation of G-quadruplex Structures in the kRAS
promoter. University of Buffalo Undergraduate Research Conference. July 2014.
Hockings, J; Brooks, TA. Identification of novel, biologically relevant, G-quadruplexes formed
within the critical promoter of kRAS as promising molecular targets. AACR Special
Conference on RAS Oncogenes: From Biology to Therapy. February 2014.
Hockings, J; Greer, KM; Brooks TA. Identification of novel, biologically relevant, Gquadruplexes formed within the critical promoter of kRAS as promising molecular targets
Proceedings of the American Association of Cancer Research (AACR), April 2013. Abstract
4374.
Kaiser, CE; Gaerig, VC; Hurley, LHH; Brooks, TA. Small molecule stabilization of the kRAS
promoter G-quadruplex as a target for novel pancreatic cancer therapeutics. Proceedings of
the American Association of Cancer Research (AACR), April 2012. Abstract 1829.
Gaerig, VC; Jin, X; Tabrizian, T; Danford, FL; Brooks, TA. Design and optimization of linked
nucleic acid (LNA) probes to detect the c-MYC G-quadruplex. Proceedings of the American
Association of Cancer Research (AACR), April 2012. Abstract 4757.
15.
Brown, RV; Gaerig, VC; Danford, FL; Hurley, LH; Brooks TA. Transcriptional downregulation
of c-Myc via G-quadruplex stabilization as novel therapy for non-Hodgkin lymphoma.
American Chemical Society, Pacifichem Meeting, December 2010.
16.
Brown, RV; Gaerig, VC; Fortin, JS; Brooks, TA. Helping Eve overcome ADAM:
Characterization of the G-quadruplex in the ADAM15 core promoter. Proceedings of the
American Association of Cancer Research (AACR), April 2010. Abstract 3681.
17.
Gaerig, VC; Fortin, JS; Brown, RV; Brooks, TA. A noel approach to develop antiVEGFR2/KDR therapeutics: characterizing and targeting the G-quadruplex. Proceedings of
the American Association of Cancer Research (AACR), April 2010. Abstract 1386.
18.
Brown, RV; Gaerig, VC; Beman, CR; Pangasa, M; Karolak, MR; Hurley, LH; Brooks, TA.
Transcriptional downregulation of c-Myc and Bcl-2 via DNA secondary structure
stabilization as novel therapy for Non-Hodgkin lymphoma. Proceedings of the American
Association of Cancer Research (AACR), April 2009. Abstract 3651.
19.
Fortin, JS; Pangasa, M; Qin, Y; Brown, RV; Kendrick, SL; Gaerig, VC; Brooks, TA; Hurley,
LH. Evaluation of G-quadruplex structures that stabilize the human PDGFR-β promoter
region as therapeutic targets for pancreatic cancer. Proceedings of the American Association
of Cancer Research (AACR), April 2009. Abstract 5377.
20.
Brooks, TA; Brown, RV; Beman, CS; Jenkins, S; Flynn, GA; Hurley, LH; Baker, AF.
Characterization of novel DNA-interactive small molecule compounds targeting
transcriptional regulation of c-Myc and Bcl-2 in Pancreatic cancer. Proceedings of the
American Association of Cancer Research (AACR), April 2008. Abstract 3199.
14 | P a g e